• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Castle Biosciences, Inc. - Common stock (NQ:CSTL)

    38.77 -0.85 (-2.15%)
    Streaming Delayed Price Updated: 11:24 AM EST, Dec 5, 2025 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 168,185
    Open 39.54
    Bid (Size) 38.66 (300)
    Ask (Size) 38.88 (100)
    Prev. Close 39.62
    Today's Range 38.52 - 40.10
    52wk Range 14.59 - 40.61
    Shares Outstanding 25,167,365
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    News headline image
    Castle Biosciences Earns a Houston Chronicle Top Workplaces Award for the Fifth Consecutive Year
    Castle also earns national recognition through three additional Top Workplaces Culture Excellence Awards — Employee Appreciation, Employee Well-Being and Professional Development 
    From Castle Biosciences, Inc.
    Via GlobeNewswire
    News headline image
    New Data Confirms Performance of DecisionDx®-Melanoma to Identify Patients with Less Than Five Percent Risk of Sentinel Lymph Node Positivity
    Second study to be presented at the 2nd European Congress on Dermato-Oncology demonstrates DecisionDx-Melanoma can identify patients with a negative sentinel lymph node who have a higher risk of poor... 
    From Castle Biosciences, Inc.
    Via GlobeNewswire

    Performance

    YTD
    +38.3%
    +38.3%
    1 Month
    +22.6%
    +22.6%
    3 Month
    +67.9%
    +67.9%
    6 Month
    +127.8%
    +127.8%
    1 Year
    +21.6%
    +21.6%

    More News

    Read More
    News headline image
    Earnings Scheduled For November 3, 2025 ↗
    Via Benzinga
    News headline image
    Castle Biosciences to Present at the Piper Sandler 37th Annual Healthcare Conference
    From Castle Biosciences, Inc.
    Via GlobeNewswire
    News headline image
    Why Castle Biosciences' Rally Might Just Be Getting Started ↗
    Via Benzinga
    News headline image
    AMD To Rally Around 12%? Here Are 10 Top Analyst Forecasts For Wednesday ↗
    Via Benzinga
    News headline image
    Castle Biosciences Reports Third Quarter 2025 Results
    From Castle Biosciences, Inc.
    Via GlobeNewswire
    News headline image
    Castle Biosciences Launches AdvanceAD-Tx™ to Help Guide Systemic Treatment Decision Making in Patients with Moderate-to-Severe Atopic Dermatitis
    From Castle Biosciences, Inc.
    Via GlobeNewswire
    News headline image
    A Glimpse of Castle Biosciences's Earnings Potential ↗
    Via Benzinga
    News headline image
    Castle Biosciences to Participate in Upcoming Investor Conferences
    From Castle Biosciences, Inc.
    Via GlobeNewswire
    News headline image
    New Data at American College of Gastroenterology Annual Meeting Show TissueCypher® Provides Actionable Risk Insights that Influence Clinical Management and Prompt Risk-Aligned Intervention in Barrett’s Esophagus
    From Castle Biosciences, Inc.
    Via GlobeNewswire
    News headline image
    New Analysis of 13,560 Patients Demonstrates DecisionDx®-Melanoma Stratifies Risk Across Histological Subtypes; Findings to be Presented at Fall Clinical Dermatology Conference
    From Castle Biosciences, Inc.
    Via GlobeNewswire
    News headline image
    Castle Biosciences to Release Third Quarter 2025 Financial Results and Host Conference Call on Monday, Nov. 3, 2025
    From Castle Biosciences, Inc.
    Via GlobeNewswire
    News headline image
    Castle Biosciences’ Founder, President and CEO Derek Maetzold Honored with the CEO of the Year Award by The CEO Magazine
    From Castle Biosciences, Inc.
    Via GlobeNewswire
    News headline image
    Castle Biosciences Honored with a Greater Pittsburgh Top Workplaces 2025 Award
    From Castle Biosciences, Inc.
    Via GlobeNewswire
    News headline image
    Castle Biosciences Named One of Newsweek’s America’s Greatest Companies 2025
    From Castle Biosciences, Inc.
    Via GlobeNewswire
    News headline image
    New Data at American Foregut Society's 2025 Annual Meeting Demonstrates TissueCypher® Can Detect High-Risk Barrett’s Esophagus Patients Not Identified by Pathology to Support Improved Care Decisions
    From Castle Biosciences, Inc.
    Via GlobeNewswire
    News headline image
    New Evidence Published Supporting Use of DecisionDx®-SCC Test in Guiding and Improving Treatment Pathway Decisions in NCCN High-Risk Cutaneous Squamous Cell Carcinoma
    From Castle Biosciences, Inc.
    Via GlobeNewswire
    News headline image
    Castle Biosciences to Participate in Upcoming Investor Conferences
    From Castle Biosciences, Inc.
    Via GlobeNewswire
    News headline image
    Here are the top movers in Tuesday's session. ↗
    Via Chartmill
    News headline image
    12 Health Care Stocks Moving In Tuesday's Intraday Session ↗
    Via Benzinga
    News headline image
    Tuesday's session: top gainers and losers ↗
    Via Chartmill
    News headline image
    Sterling Infrastructure Posts Better-Than-Expected Earnings, Joins Lemonade, DigitalOcean Holdings, Lattice Semiconductor And Other Big Stocks Moving Higher On Tuesday ↗
    Via Benzinga
    News headline image
    Traders are paying attention to the gapping stocks in Tuesday's session. ↗
    Via Chartmill
    News headline image
    These stocks are moving in today's pre-market session ↗
    Via Chartmill

    Frequently Asked Questions

    Is Castle Biosciences, Inc. - Common stock publicly traded?
    Yes, Castle Biosciences, Inc. - Common stock is publicly traded.
    What exchange does Castle Biosciences, Inc. - Common stock trade on?
    Castle Biosciences, Inc. - Common stock trades on the Nasdaq Stock Market
    What is the ticker symbol for Castle Biosciences, Inc. - Common stock?
    The ticker symbol for Castle Biosciences, Inc. - Common stock is CSTL on the Nasdaq Stock Market
    What is the current price of Castle Biosciences, Inc. - Common stock?
    The current price of Castle Biosciences, Inc. - Common stock is 38.77
    When was Castle Biosciences, Inc. - Common stock last traded?
    The last trade of Castle Biosciences, Inc. - Common stock was at 12/05/25 11:24 AM ET
    What is the market capitalization of Castle Biosciences, Inc. - Common stock?
    The market capitalization of Castle Biosciences, Inc. - Common stock is 975.74M
    How many shares of Castle Biosciences, Inc. - Common stock are outstanding?
    Castle Biosciences, Inc. - Common stock has 976M shares outstanding.
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.